David Waterhouse - Researcher Profile

Publications

3 shown

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer , Karen L. Reckamp , Paul Baas +22 more

Among patients with advanced, previously treated squamous-cell NSCLC, overall survival, response rate, and progression-free survival were significantly better with nivolumab tha...

2015 New England Journal of Medicine 8355 citations

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

Ralph Zinner , Coleman K. Obasaju , David R. Spigel +16 more

2014 Journal of Thoracic Oncology 170 citations

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

M.C. Liu , Geoffrey R. Oxnard , Eric A. Klein +97 more

2020 Annals of Oncology 1365 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 9,890
Institution: Oncology Hematology Care

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5589-9939

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.